Topical antibacterials appear to prevent exogenous colonisation or infection of the lower respiratory tract

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1232, 2000-01, pp. : 15-15

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Azithromycin and lower respiratory tract infections

By Blasi F   Cazzola M   Tarsia P   Cosentini R   Aliberti S   Santus P   Allegra L  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 13, 2005-10 ,pp. : 2335-2351

Informa Healthcare

Access to resources Recommend Favorite

Nitric oxide, peroxynitrite, and lower respiratory tract inflammation

By Robbins R.A.   Hadeli K.   Nelson D.   Sato E.   Hoyt J.C.  

Immunopharmacology, Vol. 48, Iss. 3, 2000-07 ,pp. : 217-221

Elsevier

Access to resources Recommend Favorite

Lower Respiratory Tract Infections: Impact on the Workplace

By Birnbaum H.G.  

PharmacoEconomics, Vol. 21, Iss. 10, 2003-01 ,pp. : 749-759

Adis International

Access to resources Recommend Favorite

Therapeutic options for viral lower respiratory tract infections

By  

Inpharma, Vol. 1, Iss. 1395, 2003-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Gatifloxacin in community-acquired respiratory tract infection

By Sethi Sanjay  

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 10, 2003-10 ,pp. : 1847-1855

Informa Healthcare

Access to resources Recommend Favorite